Daxor (DXR) Competitors $7.24 +0.01 (+0.14%) As of 02/21/2025 03:24 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends DXR vs. ZJYL, STIM, LNSR, ECOR, PDEX, EDAP, FONR, TELA, MLSS, and SRTSShould you be buying Daxor stock or one of its competitors? The main competitors of Daxor include Jin Medical International (ZJYL), Neuronetics (STIM), LENSAR (LNSR), electroCore (ECOR), Pro-Dex (PDEX), Edap Tms (EDAP), FONAR (FONR), TELA Bio (TELA), Milestone Scientific (MLSS), and Sensus Healthcare (SRTS). These companies are all part of the "medical equipment" industry. Daxor vs. Jin Medical International Neuronetics LENSAR electroCore Pro-Dex Edap Tms FONAR TELA Bio Milestone Scientific Sensus Healthcare Jin Medical International (NASDAQ:ZJYL) and Daxor (NASDAQ:DXR) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, dividends, analyst recommendations, community ranking, risk, valuation, profitability, institutional ownership and earnings. Does the media refer more to ZJYL or DXR? In the previous week, Daxor had 2 more articles in the media than Jin Medical International. MarketBeat recorded 3 mentions for Daxor and 1 mentions for Jin Medical International. Jin Medical International's average media sentiment score of 0.00 equaled Daxor'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Jin Medical International 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Daxor 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do insiders & institutionals have more ownership in ZJYL or DXR? 1.3% of Daxor shares are owned by institutional investors. 59.0% of Daxor shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Is ZJYL or DXR more profitable? Company Net Margins Return on Equity Return on Assets Jin Medical InternationalN/A N/A N/A Daxor N/A N/A N/A Which has more risk & volatility, ZJYL or DXR? Jin Medical International has a beta of 13.47, meaning that its share price is 1,247% more volatile than the S&P 500. Comparatively, Daxor has a beta of -0.46, meaning that its share price is 146% less volatile than the S&P 500. Which has preferable earnings & valuation, ZJYL or DXR? Jin Medical International has higher revenue and earnings than Daxor. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioJin Medical International$23.50M5.09$3.68MN/AN/ADaxor$2.61M13.44N/AN/AN/A Does the MarketBeat Community believe in ZJYL or DXR? Daxor received 1 more outperform votes than Jin Medical International when rated by MarketBeat users. CompanyUnderperformOutperformJin Medical InternationalN/AN/ADaxorOutperform Votes1100.00% Underperform VotesNo Votes Do analysts prefer ZJYL or DXR? Daxor has a consensus target price of $24.75, suggesting a potential upside of 241.85%. Given Daxor's stronger consensus rating and higher possible upside, analysts plainly believe Daxor is more favorable than Jin Medical International.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Jin Medical International 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Daxor 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryDaxor beats Jin Medical International on 8 of the 10 factors compared between the two stocks. Get Daxor News Delivered to You Automatically Sign up to receive the latest news and ratings for DXR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DXR vs. The Competition Export to ExcelMetricDaxorSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$35.02M$4.59B$5.77B$8.99BDividend YieldN/A39.91%4.78%3.85%P/E RatioN/A31.4526.4618.82Price / Sales13.4450.23453.6978.73Price / CashN/A51.2344.0437.47Price / BookN/A6.577.634.64Net IncomeN/A$90.13M$3.18B$245.69M7 Day Performance0.84%-2.20%-1.91%-2.66%1 Month Performance-10.51%-2.17%-0.19%-2.15%1 Year Performance-12.24%15.26%16.70%12.90% Daxor Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DXRDaxor3.4311 of 5 stars$7.24+0.1%$24.75+241.9%-9.5%$35.02M$2.61M0.0037ZJYLJin Medical InternationalN/A$0.86+0.5%N/A-91.0%$134.65M$23.50M0.00245Gap DownHigh Trading VolumeSTIMNeuronetics1.6444 of 5 stars$4.36+11.8%$4.67+7.0%+29.3%$132.33M$71.35M-3.54180High Trading VolumeLNSRLENSAR1.62 of 5 stars$10.50-3.7%$8.00-23.8%+98.1%$121.91M$42.16M-7.19110News CoverageECORelectroCore2.504 of 5 stars$17.41+1.4%$25.00+43.6%+151.4%$115.95M$16.03M-9.5150PDEXPro-Dex3.7438 of 5 stars$35.42+2.5%$52.00+46.8%+81.8%$115.47M$53.84M17.62140EDAPEdap Tms2.8598 of 5 stars$2.86+8.7%$19.00+564.3%-57.2%$106.11M$65.42M-4.40230High Trading VolumeFONRFONAR2.2093 of 5 stars$16.25-1.0%N/A-35.7%$102.86M$102.88M11.61480Earnings ReportNews CoverageTELATELA Bio2.8073 of 5 stars$2.61+0.4%$9.25+254.4%-61.1%$102.81M$58.45M-1.54120Positive NewsMLSSMilestone Scientific0.8096 of 5 stars$1.21+0.8%$1.25+3.3%+57.3%$94.25M$9.83M-17.2830News CoverageSRTSSensus Healthcare1.9855 of 5 stars$5.51+0.2%$14.67+166.2%+15.2%$90.31M$41.81M13.7840 Related Companies and Tools Related Companies Jin Medical International Alternatives Neuronetics Alternatives LENSAR Alternatives electroCore Alternatives Pro-Dex Alternatives Edap Tms Alternatives FONAR Alternatives TELA Bio Alternatives Milestone Scientific Alternatives Sensus Healthcare Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:DXR) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | Sponsored[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Daxor Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Daxor With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
